Adult Dosing

Symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence

• 100-200 mg PO tid-qid; decrease the dose on symptomatic relief

Pediatric Dosing

• Safety and effectiveness in pediatric patients <12 yrs of age has not been established

Symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence in children >12 yrs

• 100-200 mg PO tid-qid; decrease the dose on symptomatic relief

[Outline]

• Adult Dosing
• Pediatric Dosing

• Symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence associated with cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis

• Hypersensitivity to any of the ingredients of the product
• Pyloric or duodenal obstruction
• Obstructive intestinal lesions or ileus
• Achalasia
• GI hemorrhage
• Obstructive uropathies of the lower urinary tract

• N/A

Renal Dose Adjustment

• Renal impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic impairment: Dose adjustments not defined

• Patients should not operate motor vehicle or machinery or engage in any activities requiring mental alertness as flavoxate causes drowsiness and blurred vision
• Use cautiously in patients with suspected glaucoma

Urispas interacts with :

	Aricept
	Aricept ODT
	Donepezil
	Exelon
	Galantamine
	Razadyne
	Razadyne ER
	Rivastigmine

Pregnancy Category:B

Breastfeeding: Manufacturer advises caution.

• CNS: Vertigo, headache, mental confusion, drowsiness, dizziness, nervousness
• GI: Nausea, vomiting, dry mouth
• EENT: Increased ocular tension, blurred vision, disturbance in eye accommodation
• CV: Tachycardia, palpitations
• HYPERSENSITIVITY: Urticaria, dermatoses, eosinophilia, hyperpyrexia
• HEMA: Leukopenia
• GU: Dysuria

• Urinary tract antispasmodics; counteracts smooth muscle spasm of the urinary tract and exerts its effect directly on the muscle
• Metabolism: Unknown
• Excretion in urine (57%)
• Half-life: Unknown

US Trade Name(s)

• Only generic available

US Availability

flavoxate (generic)

• TABS: 100 mg

Canadian Trade Name(s)

• Urispas

Canadian Availability

flavoxate (generic)

• TABS: 200 mg

Urispas

• TABS: 200 mg

UK Trade Name(s)

• Urispas

UK Availability

Urispas

• TABS: 200 mg

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

[Outline]

Urologic

Antispasmodics; Urinary

Pricing data from www.DrugStore.com in U.S.A.

• Urispas 100 MG TABS [Bottle] (MCNEIL)
  28 mg = $51.99
  84 mg = $145.97

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.

Drug Name: Flavoxate 100 MG Oral Tablet

Ingredient(s): Flavoxate

Imprint: PAD;0115

Color(s): White

Shape: Round

Size (mm): 11.00

Score: 1

Inactive Ingredient(s): colloidal silicon dioxide / ethyl acrylate / hypromellose / lactose monohydrate / magnesium stearate / methyl methacrylate / microcrystalline cellulose / nonoxynol 100 / sodium starch glycolate / hypromellose 2910 6cp / polyethylene glycol

Drug Label Author:
Paddock Laboratories, Inc.

DEA Schedule:
Non-Scheduled

Drug Name: Urispas 100 MG Oral Tablet

Ingredient(s): Flavoxate

Imprint: URISPAS

Color(s): White

Shape: Round

Size (mm): 10.00

Score: 1

Inactive Ingredient(s): calcium phosphate / hypromellose / magnesium stearate / polyethylene glycol / starch / talc

Drug Label Author:
ORTHO-McNEIL PHARMACEUTICAL, INC.

DEA Schedule:
Non-Scheduled